Clinicopathological correlations in behavioural variant frontotemporal dementia
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Accurately predicting the underlying neuropathological diagnosis in patients with behavioural variant frontotemporal dementia (bvFTD) poses a daunting challenge for clinicians but will be critical for the success of disease-modifying therapies. We sought to improve pathological prediction by exploring clinicopathological correlations in a large bvFTD cohort. Among 438 patients in whom bvFTD was either the top or an alternative possible clinical diagnosis, 117 had available autopsy data, including 98 with a primary pathological diagnosis of frontotemporal lobar degeneration (FTLD), 15 with Alzheimer's disease, and four with amyotrophic lateral sclerosis who lacked neurodegenerative disease-related pathology outside of the motor system. Patients with FTLD were distributed between FTLD-tau (34 patients: 10 corticobasal degeneration, nine progressive supranuclear palsy, eight Pick's disease, three frontotemporal dementia with parkinsonism associated with chromosome 17, three unclassifiable tauopathy, and one argyrophilic grain disease); FTLD-TDP (55 patients: nine type A including one with motor neuron disease, 27 type B including 21 with motor neuron disease, eight type C with right temporal lobe presentations, and 11 unclassifiable including eight with motor neuron disease), FTLD-FUS (eight patients), and one patient with FTLD-ubiquitin proteasome system positive inclusions (FTLD-UPS) that stained negatively for tau, TDP-43, and FUS. Alzheimer's disease was uncommon (6%) among patients whose only top diagnosis during follow-up was bvFTD. Seventy-nine per cent of FTLD-tau, 86% of FTLD-TDP, and 88% of FTLD-FUS met at least 'possible' bvFTD diagnostic criteria at first presentation. The frequency of the six core bvFTD diagnostic features was similar in FTLD-tau and FTLD-TDP, suggesting that these features alone cannot be used to separate patients by major molecular class. Voxel-based morphometry revealed that nearly all pathological subgroups and even individual patients share atrophy in anterior cingulate, frontoinsula, striatum, and amygdala, indicating that degeneration of these regions is intimately linked to the behavioural syndrome produced by these diverse aetiologies. In addition to these unifying features, symptom profiles also differed among pathological subtypes, suggesting distinct anatomical vulnerabilities and informing a clinician's prediction of pathological diagnosis. Data-driven classification into one of the 10 most common pathological diagnoses was most accurate (up to 60.2%) when using a combination of known predictive factors (genetic mutations, motor features, or striking atrophy patterns) and the results of a discriminant function analysis that incorporated clinical, neuroimaging, and neuropsychological data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because isolated rATL atrophy is highly predictive of TDP-C pathology, recent studies have highlighted the importance of characterizing and isolating this syndrome from other FTD syndromes.6”
From Automated Speech Analysis to Differentiate Frontal and Right Anterior Temporal Lobe Atrophy in Frontotemporal Dementia (2025) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternatively, lesions of the Alzheimer type are frequently observed as copathology in post-mortem examination of people who had other neurodegenerative diseases.40,41,94,96”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [96]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, loss of function of GRN alkalinizes lysosomes, while PD-associated mutations in TMEM175, a lysosomal proton leak channels, hyper-acidifies lysosomes.129,130”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [129]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, loss of function of GRN alkalinizes lysosomes, while PD-associated mutations in TMEM175, a lysosomal proton leak channels, hyper-acidifies lysosomes.129,130”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [129]
Experimental — accuracy not yet measuredIn the citing paper
“This biomarker positivity is particularly ambiguous in the case of behavioural or dysexecutive variants, corticobasal syndrome, and semantic or non-fluent variants of primary progressive aphasia, in which the presence of positive Alzheimer’s disease biomarkers can be considered either as Alzheimer’s disease copathology or atypical forms of Alzheimer’s disease94,96,98,99 (appendix p 2).”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,039
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 3×
“This determination was made by the reviewing clinician as has been done in prior papers establishing the sensitivity and interrater reliability of these criteria (Rascovsky et al., 2011; Lamarre et al., 2013).”
BackgroundMethodSelf-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Self-citationHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · cited 1×
“Patients were classified into FTLD major molecular classes (tau, TDP-43, or FUS) and subtypes (Mackenzie et al., 2010, 2011), Alzheimer’s disease (Hyman and Trojanowski, 1997; Hyman et al., 2012), or amyotrophic lateral sclerosis (ALS).”
BackgroundSelf-citationAppelhof, B., Bakker, C., Van Duinen-van den Ijssel, J. C. L., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,760
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L., & Greicius, M. D. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.024 · Cited by 2,350
Self-citation
Cited by
Items 101–200 of 325
Increased Cortical Thickness in Alzheimer's Disease
Phan, T. X., Baratono, S. R., Drew, W., Tetreault, A. M., Fox, M., Darby, R. R., & Initiative, A. D. N. (2024) · Annals of Neurology · doi:10.1002/ana.26894 · Cited by 32
Illán‐Gala, I., Falgàs, N., Friedberg, A., Castro‐Suárez, S., Keret, O., Rogers, N., Öz, D., Nigro, S. L., Quattrone, A., Quattrone, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.1290 · Cited by 27
Self-citationThe glymphatic system and Amyotrophic lateral sclerosis
Eisen, A., Nedergaard, M., Gray, E., & Kiernan, M. C. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102571 · Cited by 28
Lorca‐Puls, D. L., Gajardo‐Vidal, A., Mandelli, M. L., Illán‐Gala, I., Ezzes, Z., Wauters, L., Battistella, G., Bogley, R., Ratnasiri, B. M., Licata, A. E., et al. (2023) · Brain · doi:10.1093/brain/awad327 · Cited by 27
Self-citationWong, S., Strudwick, J., Devenney, E. M., Hodges, J. R., Piguet, O., & Kumfor, F. (2019) · Neurocase · doi:10.1080/13554794.2019.1609523 · Cited by 25
FRONTotemporal dementia Incidence European Research Study—FRONTIERS: Rationale and design
Borroni, B., Graff, C., Hardiman, O. M., Ludolph, A. C., Moreno, F., Otto, M., Piccininni, M., Remes, A. M., Rowe, J. B., Seelaar, H., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12414 · Cited by 25
“tral populations and countries? (3) Should FTLD-related disorders be consideredadisorder ofmidlife? (4) Is bvFTDmore common thanPPAs, or vice versa? (5) Are FTLD-related disorders associated with specific risk factors? (6) Is distribution of FTLD-related disorders comparable across Europe? (7)Which is the impact ofmon…”
BackgroundMcKenna, M. C., Lope, J., Bede, P., & Tan, E. L. (2023) · Brain and Behavior · doi:10.1002/brb3.2881 · Cited by 28
“Postmortem studies have confirmed thalamic atrophy in all FTD phenotypes, sometimes commenting on the affected region (Broe et al., 2003), but seldom mentioning specific nuclei (Broe et al., 2003; Cykowski et al., 2016; Mann & South, 1993; Perry et al., 2017; Rohrer et al., 2010).”
BackgroundRisacher, S. L., & Apostolova, L. G. (2023) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001248 · Cited by 26
Li, C., Fan, S., Chen, T., Chiu, M., Yen, R., & Lin, C. (2020) · Brain and Behavior · doi:10.1002/brb3.1548 · Cited by 25
“…be misdiagnosed as FTD, accounting for 10%–30% of clinically diagnosed FTD patients by clinicopathological correlation, which may lead to underestimations of the true prevalence of fvAD (Forman et al., 2006; Mendez, Joshi, Tassniyom, Teng, & Shapira, 2013; Perry et al., 2017; Tan et al., 2017).”
BackgroundNeuroimaging Abnormalities in Neurological Patients with Criminal Behavior
Darby, R. R. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0853-3 · Cited by 28
Kassubek, J., Müller, H.-P., Del Tredici, K., Hornberger, M., Schroeter, M. L., Müller, K., Anderl-Straub, S., Uttner, I., Grossman, M., Braak, H., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00047 · Cited by 23
Brain perfusion SPECT in dementia: what radiologists should know
Imokawa, T., Yokoyama, K., Takahashi, K., Oyama, J., Tsuchiya, J., Sanjo, N., & Tateishi, U. (2024) · Japanese Journal of Radiology · doi:10.1007/s11604-024-01612-5 · Cited by 25
“Furthermore, atrophy of the bilateral fronto-insular, anterior to mid-cingulate cortex, amygdala, and striatum was common regardless of pathology and could be degenerative regions closely related to behavioral abnormalities [94].”
BackgroundFrontotemporal dementia. How to deal with its diagnostic complexity?
Antonioni, A., Raho, E. M., Granieri, E., & Koch, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2461758 · Cited by 25
“Notably, the right hemisphere generally exhibits more pronounced atrophy than the left in the early stages [219].”
The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis
Martinelli, I., Zucchi, E., Simonini, C., Gianferrari, G., Zamboni, G., Pinti, M., & Mandrioli, J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.361535 · Cited by 25
“Exploring clinicopathological correlations in a large bvFTD cohort, Perry et al. (2017) found that patients with frontotemporal lobar degeneration associated with FUS were younger and had more severe behavioral impairment than all other bvFTD groups.”
BackgroundResultCingulate-centered large-scale networks: Normal functions, aging, and neurodegenerative disease
Touroutoglou, A., & Dickerson, B. C. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64196-0.00008-x · Cited by 24
The problematic syndrome of right temporal lobe atrophy: Unweaving the phenotypic rainbow
Belder, C. R. S., Chokesuwattanaskul, A., Marshall, C. R., Hardy, C. J. D., Rohrer, J. D., & Warren, J. D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1082828 · Cited by 23
“Furthermore, there is a strong, joint association with TAR-DNA-binding-protein (TDP)-43 type C as the underlying proteinopathy (3, 6, 11), albeit with greater genetic and histopathological heterogeneity in RTLA (18, 19).”
BackgroundHazelton, J. L., Carneiro, F., Maito, M., Richter, F., Legaz, A., Altschuler, F., Cubillos-Pinilla, L., Chen, Y., Doherty, C. P., Baez, S., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.10.013 · Cited by 21
Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum
Illán‐Gala, I., Lorca‐Puls, D. L., Tee, B. L., Ezzes, Z., de Leon, J., Miller, Z., Rubio‐Guerra, S., Santos‐Santos, M., Gómez‐Andrés, D., Grinberg, L. T., et al. (2023) · Brain · doi:10.1093/brain/awad396 · Cited by 21
“27,28 Briefly, participants were classified post-mortem into FTLD major molecular classes and subtypes, and genetic screening was conducted for mutations known to cause autosomal dominant FTLD or Alzheimer’s disease in the participants giving their informed consent.”
BackgroundSelf-citationCordero, I. R. G., Anastassiadis, C., Khoja, A. A., Morales‐Rivero, A., Thapa, S., Vasilevskaya, A., Davenport, C., Sumra, V., Couto, B., Multani, N., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26930 · Cited by 22
“Con fi rmed neuropathological cases of FTLD demonstrate atrophy and accumulation of FTLD-associated pathological inclusions in areas that are hubs of SN. 44 In our case, it is likely that the 4-”
Self-citationChu, M. K., Liu, L., Wang, J., Liu, L., Kong, Y., Jing, D., Xie, K., Cui, Y., Cui, B., Zhang, J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215127 · Cited by 21
Taylor, J. C., Heuer, H. W., Clark, A. L., Wise, A. B., Manoochehri, M., Forsberg, L., Mester, C., Rao, M., Brushaber, D., Kramer, J., et al. (2023) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12423 · Cited by 20
Self-citationPosterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer’s Disease
Bergeron, D., Beauregard, J., Jean-Guimond, Soucy, J., Verret, L., Poulin, S. P., Matías‐Guiu, J. A., Cabrera‐Martín, M. N., Bouchard, R. W., & Laforce, R. J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200567 · Cited by 20
PET Neuroimaging in Dementia Conditions
Perani, D., Caminiti, S. P., Carli, G., & Tondo, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_9 · Cited by 21
Quattrone, A., Morelli, M., Bianco, M. G., Buonocore, J., Sarica, A., Caligiuri, M. E., Aracri, F., Calomino, C., Maria, M. D., Vaccaro, M. G., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12070949 · Cited by 21
Factors that predict diagnostic stability in neurodegenerative dementia
Perry, D. C., Datta, S., Miller, Z., Rankin, K. P., Gorno‐Tempini, M. L., Kramer, J. H., Rosen, H. J., Seeley, W. W., & Miller, B. L. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09362-5 · Cited by 21
Self-citationNeuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis
Tredici, K. D., & Braak, H. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001098 · Cited by 19
Advances in the treatment and management of frontotemporal dementia
Benussi, A., & Borroni, B. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2228491 · Cited by 19
Llibre‐Guerra, J. J., Lee, S. E., Suemoto, C. K., Ehrenberg, A. J., Kovács, G. G., Karydas, A., Staffaroni, A. M., Resende, E. D. P. F., Kim, E., Hwang, J., et al. (2021) · Brain Pathology · doi:10.1111/bpa.12924 · Cited by 20
“The clinical diagnosis for each patient was rendered at a multidisciplinary consensus meeting individually based on the reviewing clinical history, physical examination, neuropsychological evaluation, and structural MRI brain imaging (26,27).”
MethodSelf-citationWhiteside, D. J., Holland, N., Tsvetanov, K. A., Mak, E., Malpetti, M., Savulich, G., Jones, P. S., Naessens, M., Rouse, M. A., Fryer, T. D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-44307-7 · Cited by 19
“Reduced grey matter volumes in bvFTD compared to CBS and PSP (Supplementary Table 5) were found in the frontal and tem-porallobes, the cingulate, insula, and caudate, with reductions for CBS compared to PSP in the precentral gyri.”
BackgroundInfluentialIn vivo PET classification of tau pathologies in patients with frontotemporal dementia
Kubota, M., Endo, H., Takahata, K., Tagai, K., Suzuki, H., Onaya, M., Sano, Y., Yamamoto, Y., Kurose, S., Matsuoka, K., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae075 · Cited by 18
“46 Our clinical assessments showed that patients with bvFTD in this study had severe apathy, disinhibition, behavioural disturbances and diet-and sleep-related disturbances (Fig.”
InfluentialBehavioural changes in frontotemporal dementia and their cognitive and neuroanatomical correlates
Rouse, M. A., Husain, M., Garrard, P., Patterson, K. E., Rowe, J. B., & Ralph, M. A. L. (2025) · Brain · doi:10.1093/brain/awaf061 · Cited by 22
“87 Consequently, accurate diagnosis is vital for clinical trial stratification, to ensure that any participant in a trial has the proteinopathy that the drug is targeting.”
Neuropsychiatric Aspects of Frontotemporal Dementia
Younes, K., & Miller, B. L. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.005 · Cited by 14
Self-citationMcKenna, M. C., Tahedl, M., Lope, J., Chipika, R. H., Shing, S. L. H., Doherty, M. A., Hengeveld, J. C., Vajda, A., McLaughlin, R. L., Hardiman, O. M., et al. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00523-7 · Cited by 18
Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers
Katisko, K., Cajanus, A., Korhonen, T., Remes, A. M., Haapasalo, A., & Solje, E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00658 · Cited by 22
Liu, A., Chang, J. E., Naasan, G., Boxer, A. L., Miller, B. L., & Spina, S. (2020) · Neurocase · doi:10.1080/13554794.2020.1732427 · Cited by 18
“Because of the extensive anatomical, pathological, and clinical overlap between the various FTLD subtypes, the prediction of a specific neuropathological substrate in vivo, given any clinical presentation, remains complex (Perry et al., 2017).”
BackgroundSelf-citationDiversity-sensitive brain clocks linked to biophysical mechanisms in aging and dementia
Coronel‐Oliveros, C., Moguilner, S., Hernandez, H., Cruzat, J., Báez, S., Medel, V., Cuadros, J., Santamaría‐García, H. A., Valdes-Sosa, P. A., Lopera, F. J., et al. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00502-7 · Cited by 19
Benussi, A., Agosta, F., Alfano, A. R., Antico, A., Bellelli, G., Bonanni, L., Bottini, G., Bozzali, M., Brignoli, O., Bruno, G., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08576-y · Cited by 18
Liu, X., TYLER, L. K., Cam‐CAN, Rowe, J. B., & Tsvetanov, K. A. (2022) · Human Brain Mapping · doi:10.1002/hbm.26025 · Cited by 17
“…not fully explain cognitive performance (Boekel et al., 2015) and is insufficient for understanding aging and neurodegenerative syndromes with heterogenous clinical features (Grajauskas et al., 2019; Murley et al., 2020; Perry et al., 2017; Tsvetanov et al., 2016; Tsvetanov, Gazzina, et al., 2021).”
MRI of non-Alzheimer's dementia: current and emerging knowledge
Filippi, M., & Agosta, F. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000571 · Cited by 18
Paolillo, E. W., Casaletto, K. B., Clark, A. L., Taylor, J. C., Heuer, H. W., Wise, A. B., Dhanam, S., Sanderson-Cimino, M., Saloner, R., Kramer, J. H., et al. (2024) · JMIR Aging · doi:10.2196/52831 · Cited by 16
“FTLD encompasses a group of neuropathologically distinct diseases that result in an overlapping set of dementia syndromes with heterogeneous symptoms, including those defined by primary behavior, language, or sensorimotor changes [3,4].”
BackgroundSelf-citationVonk, J. M. J., Borghesani, V., Battistella, G., Younes, K., DeLeon, J., Welch, A., Hubbard, H. I., Miller, Z. A., Miller, B. L., & Gorno-Tempini, M. L. (2020) · Aphasiology · doi:10.1080/02687038.2019.1659935 · Cited by 16
“This could explain why the behavioral symptoms observed in individuals with the right variant of ATL degeneration can overlap with those detected in the bvFTD (Rascovsky et al., 2011), even though the underlying pathology greatly differs (Perry et al., 2017; Spinelli et al., 2017).”
BackgroundSelf-citationI'm looking through you: Mentalizing in frontotemporal dementia and progressive supranuclear palsy
de Souza, L. C., Bertoux, M., Radaković, R., Hornberger, M., Mariano, L. I., Resende, E. D. P. F., Quesque, F., Guimarães, H. C., Gambogi, L. B., Tumas, V., et al. (2022) · Cortex · doi:10.1016/j.cortex.2022.07.015 · Cited by 17
Neuropsychiatric symptoms and imbalance of atrophy in behavioral variant frontotemporal dementia
Sokołowski, A., Roy, A. R. K., Goh, S. M., Hardy, E. G., Datta, S., Cobigo, Y., Brown, J. A., Spina, S., Grinberg, L. T., Kramer, J. H., et al. (2023) · Human Brain Mapping · doi:10.1002/hbm.26428 · Cited by 17
Self-citationAgosta, F., Basaia, S., Spinelli, E. G., Facente, F., Lumaca, L., Ghirelli, A., Canu, E., Castelnovo, V., Sibilla, E., Tripodi, C., et al. (2024) · Brain · doi:10.1093/brain/awae391 · Cited by 17
“…absence of a pathological staging of tau pathology in FTLD or any definite in vivo biomarker to distinguish between the two main FTLD pathologies, 41 there is still uncertainty regarding divergence in the location of disease epicentres and ‘target’ networks according to the underlying…”
FTLD Treatment: Current Practice and Future Possibilities
Ljubenkov, P. A., & Boxer, A. L. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_18 · Cited by 16
Self-citationProton magnetic resonance spectroscopy in frontotemporal lobar degeneration-related syndromes
Murley, A. G., Tsvetanov, K. A., Rouse, M. A., Jones, P. S., Sværke, K., Li, W., Carpenter, T. A., & Rowe, J. B. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.10.012 · Cited by 16
Henríquez, F., Cabello, V., Báez, S., de Souza, L. C., Lillo, P., Martínez‐Pernía, D., Olavarría, L., Torralva, T., & Slachevsky, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.768591 · Cited by 18
“Considering a huge amount of evidence suggesting that FTDrelated clinical syndromes are associated with heterogeneous pathology (262), it is important to emphasize that recommended tests allow prediction of a clinical syndrome, but not of a given specific pathological diagnosis (263).”
BackgroundMcKenna, M. C., Murad, A. A., Huynh, W., Lope, J., & Bede, P. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2048648 · Cited by 16
Shdo, S. M., Roy, A. R. K., Datta, S., Sible, I. J., Lukic, S., Perry, D. C., Rankin, K. P., Kramer, J. H., Rosen, H. J., Miller, B. L., et al. (2022) · Cortex · doi:10.1016/j.cortex.2022.02.018 · Cited by 16
Self-citationFrontotemporal dementia: A unique window on the functional role of the temporal lobes
Borghesani, V., Deleon, J., & Gorno‐Tempini, M. L. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823493-8.00011-0 · Cited by 17
Self-citationIdentifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry
Ducharme, S., Pijnenburg, Y. A. L., Rohrer, J. D., Huey, E. D., Finger, E. C., & Tatton, N. A. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.08.017 · Cited by 22
“54,55 Approximately 15% of patients with FTD show comorbid motor neuron disease (FTD-MND), while an additional 27% of patients show some evidence of motor dysfunction during the disease course 56 .”
Background(2023) · doi:10.2196/preprints.52831 · Cited by 16
Perez, S. D., Phillips, J. S., Norise, C., Kinney, N. G., Vaddi, P., Halpin, A., Rascovsky, K., Irwin, D. J., McMillan, C. T., Xie, L., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215728 · Cited by 15
Association of APOE ε4/ε4 with fluid biomarkers in patients from the PUMCH dementia cohort
Shang, L., Dong, L., Huang, X., Wang, T., Mao, C., Li, J., Wang, J., Liu, C., & Gao, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1119070 · Cited by 15
Godfrey, R. K., Alsop, E. B., Bjork, R. T., Chauhan, B. S., Ruvalcaba, H. C., Antone, J., Gittings, L. M., Michael, A. F., Williams, C., Hala’ufia, G., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01656-0 · Cited by 15
de Souza, L. C., Hosogi, M. L., Machado, T. H., Carthery‐Goulart, M. T., Yassuda, M. S., Smid, J., Barbosa, B. J. A. P., Schilling, L. P., Balthazar, M. L. F., Frota, N. A. F., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s103pt · Cited by 27
Prediction of neuropathologic lesions from clinical data
Phongpreecha, T., Cholerton, B., Bukhari, S. A., Chang, A. L., Francesco, D. D., Thuraiappah, M., Godrich, D., Perna, A., Becker, M., Ravindra, N. G., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12921 · Cited by 14
Youssef, H., Weissmann, C., Uruk, G., & Gatto, R. G. (2025) · Brain Sciences · doi:10.3390/brainsci15070716 · Cited by 15
“…evident in the analysis of specific FTLD histopathological subtypes, where significant overlap in core clinical criteria, symptoms, and additional cognitive and behavioral characteristics wasobserved, alongside convergent patterns of grey matter atrophy across multiple pathological subtypes [81].”
Matyi, M. A., Radhakrishnan, H., Olm, C. A., Phillips, J. S., Cook, P. A., Rhodes, E., Gee, J. C., Irwin, D. J., McMillan, C. T., & Massimo, L. M. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103853 · Cited by 14
“…an interesting future direction as evidence demonstrates convergence of tau and TDP-43 pathology on select paralimbic cells in the salience network (Perry et al., 2017; Seeley et al., 2006, Seeley et al., 2008, 2009) but partially distinct cellular degeneration patterns (Chen et al., 2022; Irwin…”
Broce, I., Castruita, P. A., & Yokoyama, J. S. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.639078 · Cited by 15
Truncated TDP‐43 proteoforms diagnostic of frontotemporal dementia with TDP‐43 pathology
Forgrave, L. M., Moon, K., Hamden, J. E., Li, Y., Lu, P., Foster, L. J., Mackenzie, I. R., & DeMarco, M. L. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13368 · Cited by 13
“3,4 As such, a biomarker that can detect the most common FTD pathology, FTLD-TDP, and distinguish it from disorders with overlapping clinical phenotypes is highly desired.”
BackgroundChronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia
Lesman‐Segev, O. H., Edwards, L., & Rabinovici, G. D. (2020) · Seminars in Neurology · doi:10.1055/s-0040-1715134 · Cited by 14
Self-citationMcKenna, M. C., Tahedl, M., Murad, A. A., Lope, J., Hardiman, O. M., Hutchinson, S., & Bede, P. (2022) · Brain and Behavior · doi:10.1002/brb3.2500 · Cited by 13
“…linked to pTDP-43 (Geser et al., 2011), svPPA is nearly always associated with underlying TDP-43-C pathological aggregates (Bocchetta et al., 2020), nfvPPA is commonly associatedwith 4R tau (Spinelli et al., 2017) and molecular findings in bvFTD are thought to be heterogeneous (Perry et al., 2017).”
BackgroundFlies, C. M., & Veldink, J. H. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1733021 · Cited by 12
“Mutations in this gene are known to cause a familial or sporadic ALS type 6 phenotype (1,2), including young-onset ALS, ALS/frontotemporal dementia (FTD) and rarely pure FTD (1,3).”
BackgroundPhases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology
Burke, S., Phillips, J. S., Olm, C. A., Peterson, C. S., Cook, P. A., Gee, J. C., Lee, E. B., Trojanowski, J. Q., Massimo, L. M., Irwin, D. J., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.02.007 · Cited by 12
Self-citationSantillo, A. F., Leuzy, A., Honer, M., Waldö, M. L., Tideman, P., Harper, L., Ohlsson, T. G., Moes, S., Giannini, L., Jögi, J., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-06065-4 · Cited by 12
Self-citationCytoarchitectonic gradients of laminar degeneration in behavioural variant frontotemporal dementia
Ohm, D. T., Xie, S. X., Capp, N., Arezoumandan, S., Cousins, K. A. Q., Rascovsky, K., Wolk, D. A., Deerlin, V. M. V., Lee, E. B., McMillan, C. T., et al. (2024) · Brain · doi:10.1093/brain/awae263 · Cited by 11
Gnoni, V., Tamburrino, L., Baldazzi, G., Urso, D., Zoccolella, S., Giugno, A., Figorilli, M., Nigro, S. L., Tafuri, B., Vilella, D., et al. (2024) · SLEEP · doi:10.1093/sleep/zsae201 · Cited by 12
“More recently, Perry et al. demonstrated that atrophy in the anterior cingulate, frontoinsula, striatum, and amygdala are associated with behavioral symptoms, including sleep disorders, in bvFTD patients [49].”
Brumberg, J., Schröter, N., Blazhenets, G., Omrane, M. A., Volz, C., Weiller, C., Rijntjes, M., Frings, L., Hellwig, S., Jost, W. H., et al. (2025) · Journal of Nuclear Medicine · doi:10.2967/jnumed.124.268956 · Cited by 11
“…each) are in line with the previous literature and may be related to the occurrence of 4R tau pathology in non fl uent variant primary progressive aphasia and behavioral variant FTD ( 26,27 ) or to misclassi fi cation because of possible off-target binding of [ 18 F] fl orzolotau in MSA ( 28 ).”
Functional Imaging for Neurodegenerative Diseases
Chollet, F., & Payoux, P. (2022) · La Presse Médicale · doi:10.1016/j.lpm.2022.104121 · Cited by 11
Bipolar spectrum disorders in neurologic disorders
Digiovanni, A., Ajdinaj, P., Russo, M., Sensi, S. L., ONOFRJ, M. C., & Thomas, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1046471 · Cited by 15
“Visual hallucinations, which were initially considered a feature of dementia with Lewy bodies (DLB), are described in C9orf72 and GRN genetic variant carriers (25).”
BackgroundTian, X., Qin, Y., Tian, Y., Ge, X., Cui, J., Han, H., Liu, L., & Yu, H. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1860966 · Cited by 14
“be a multifactorial syndrome whose pathology results from the interaction of multiple genes [31].”
BackgroundInfluentialRisacher, S. L. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001509 · Cited by 11
Shepherd, T. M., & Nayak, G. K. (2019) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000225 · Cited by 11
“Radiologists should also be aware that the PET-MRI findings (or postmortem diagnosis) may be discordant with the clinical diagnosis, just as clinical diagnoses can be discordant with pathology.(85,86) A key consideration is how to report the findings– while we try to avoid ambiguity and explicitly mention specific dia…”
Do Patients with Progressive Supranuclear Palsy Have Episodic Memory Impairment? A Systematic Review
Macedo, A. C., Mariano, L. I., Martins, M. I., Friedlaender, C. V., Balbino, J. M. V., Rocha, J. V. D. F., Camargos, S., Cardoso, F., Caramelli, P., & de Souza, L. C. (2022) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13435 · Cited by 12
“This is somewhat unexpected, as atrophy in critical structures for episodic memory, such as Papez’s circuit and medial temporal lobe, are supposed to be intact in early PSP,57 but have been described in FTD.58 Indeed, the classical concept of preservation of episodic memory in FTD59 has been challenged by a series of…”
BackgroundInfluentialVonk, J. M. J., Morin, B. T., Pillai, J., Rosado Rolon, D., Bogley, R., Baquirin, D. P., Ezzes, Z., Tee, B. L., de Leon, J., Wauters, L., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213556 · Cited by 10
Self-citationRajbanshi, B., Araujo, I. P. Q. C., VandeVrede, L. A., Ljubenkov, P. A., Staffaroni, A. M., Heuer, H. W., Lago, A. L., Ramos, E. M., Petrucelli, L., Gendron, T. F., et al. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70078 · Cited by 15
Self-citationPhan, T. X., Reeder, J. E., Keener, L. C., Considine, C. M., Zald, D. H., Claassen, D. O., & Darby, R. R. (2023) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20220135 · Cited by 11
Schönecker, S., Martínez-Murcia, F. J., Denecke, J., Franzmeier, N., Danek, A., Wagemann, O., Prix, C., Wlasich, E., Vöglein, J., Loosli, S. V., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209569 · Cited by 13
Self-citationChu, M. K., Jiang, D., Liu, L., Nie, B., Rosa‐Neto, P., Chen, K., & Wu, L. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.01.004 · Cited by 11
Paquin, V., Therriault, J., Pascoal, T. A., Rosa‐Neto, P., & Gauthier, S. G. (2020) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0000000000000251 · Cited by 11
Vuksanović, V., Staff, R. T., Morson, S. M., Ahearn, T. S., Bracoud, L., Murray, A. D., Bentham, P., Kipps, C., Harrington, C. R., & Wischik, C. M. (2021) · Brain Communications · doi:10.1093/braincomms/fcab241 · Cited by 10
Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
Fiondella, L., Gami‐Patel, P., Blok, C. A., Rozemüller, A. J. M., Hoozemans, J. J. M., Bank, T. N. B., Pijnenburg, Y. A. L., Scarioni, M., & Dijkstra, A. A. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01560-7 · Cited by 9
“However, considering that other authors presented similar results [5, 13, 24], MD could not be considered as exclusively predictive of FTLD-tau.”
BackgroundResultLiu, F., Shi, Y., Wu, Q., Chen, H., Wang, Y., Cai, L., & Zhang, N. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14418 · Cited by 11
“Postmortem studies showed that ~ 15%– 20% of clinically diagnosed bvFTD cases could be caused by AD pathology, 29,30 also known as “the fvAD.””
BackgroundVieira, É. L. M., Caramelli, P., Rocha, N. P., Cardoso, M. G. D. F., de Miranda, A. S., Teixeira, A. L., & de Souza, L. C. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577531 · Cited by 9
Striatal dopaminergic patterns and clinical features in frontotemporal dementia
Urso, D., Anastasia, A., Gnoni, V., Giugno, A., Vilella, D., Vitulli, A., Zecca, C., Pineda‐Pardo, J. A., Foffani, G., Obeso, J. A., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf284 · Cited by 8
“Interestingly, fused in sarcoma (FUS), one of the key proteins implicated in FTLD-FET, 60 is associated with early and prominent caudate atrophy.”
Singleton, E. H., Pijnenburg, Y. A. L., Gami‐Patel, P., Boon, B. D. C., Bouwman, F. H., Papma, J. M., Seelaar, H., Scheltens, P., Grinberg, L. T., Spina, S., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00947-9 · Cited by 8
Self-citationConstantinides, V. C., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Ghika, A., Koros, C., Liakakis, G., Papageorgiou, S. G., Stefanis, L., Paraskevas, G. P., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13030332 · Cited by 9
“In the largest cohort of bvFTD patients with a neuropathological confirmation to date, 13% of patients had an AD pathology [2].”
BackgroundResultBatzikosta, A., Μoraitou, D., Steiropoulos, P., Παπαντωνίου, Γ., Kougioumtzis, G. Α., Katsouri, I.-G., Sofologi, M., & Tsolaki, M. (2025) · Brain Sciences · doi:10.3390/brainsci15010057 · Cited by 8
“Impairments in functional connectivity within the prefrontal cortex and DMN are hallmark features of MCI and profoundly affect the ability to understand intentions [76–78].”
Tan, R. H., Yang, Y., McCann, H., Shepherd, C. E., & Halliday, G. M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180900 · Cited by 8
de Souza, L. C., Mariano, L. I., de Moraes, R. F., & Caramelli, P. (2019) · Dementia & Neuropsychologia · doi:10.1590/1980-57642018dn13-030015 · Cited by 9
“Dement Neuropsychol 2019 September;13(3):356-360”
Probing individual-level structural atrophy in frontal glioma patients
Zhang, G., Zhang, X., Huang, H.-W., Wang, Y., Li, H., Duan, Y., Chen, H., Liu, Y., Jing, B., Tie, Y., et al. (2022) · Neurosurgical Review · doi:10.1007/s10143-022-01800-9 · Cited by 8
Nabizadeh, F., Pirahesh, K., Aarabi, M. H., Wennberg, A. M. V., & Pini, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29420 · Cited by 9
“In bAD, several studies consistently reported brain atrophy in regions involved in behavioral controls, such as insula, orbitofrontal cortex, frontal gyrus, and anterior cingulate cortex [8,18,29,30].”
BackgroundPasquini, L., Pereira, F. L., Seddighi, S., Zeng, Y., Wei, Y., Illán‐Gala, I., Vatsavayai, S. C., Friedberg, A., Lee, A. J., Brown, J. A., et al. (2024) · Brain · doi:10.1093/brain/awae205 · Cited by 8
“58,59 Structural MRI volumes were segmented into grey matter tissue probability maps and further transformed to W-score maps, 37,38 where higher W-scores reflect more severe voxel-wise atrophy for each patient, adjusted for demographic variables.”
MethodSelf-citationde Souza, L. C., Hosogi, M. L., Machado, T. H., Carthery‐Goulart, M. T., Yassuda, M. S., Smid, J., Barbosa, B. J. A. P., Schilling, L. P., Balthazar, M. L. F., Frota, N. A. F., et al. (2022) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2022-s103en · Cited by 12
Mapping frontoinsular cortex from diffusion microstructure
Cabeen, R. P., Toga, A. W., & Allman, J. M. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac237 · Cited by 8
Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers
Álvarez‐Sánchez, L., Peña‐Bautista, C., Ferré‐González, L., Cubas-Núñez, L., Balaguer, Á., Casanova-Estruch, B., Baquero, M., & Cháfer‐Pericás, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814151 · Cited by 9
“The FTD syndrome could occasionally manifest as an AD-like amnestic syndrome, mostly in older patients [36].”
BackgroundBroce, I., Sirkis, D. W., Nillo, R. M., Bonham, L. W., Lee, S. E., Miller, B. L., Castruita, P. A., Sturm, V. E., Sugrue, L. P., Desikan, R. S., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1258996 · Cited by 7
“…with bvFTD manifest with dysexecutive and behavioral symptoms because neurons within specific regions of the brain underlying executive function and social behavior (e.g., anterior cingulate, anterior insula, striatum, and amygdala) are impacted (Perry et al., 2017; Vatsavayai et al., 2019).”
BackgroundSelf-citationCranston, A., Kraev, I., Stewart, M. G., Horsley, D., Santos, R. X., Robinson, L., Dreesen, E., Armstrong, P., Palliyil, S., Harrington, C. R., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111269 · Cited by 8
Giagkou, N., Kapsali, I., Brinia, M.-E., & Constantinides, V. C. (2024) · Biomedicines · doi:10.3390/biomedicines12081781 · Cited by 7
“Thus, a bvFTD phenotype may be due to an underlying FTLD-tau pathology (~40–50%), FTLD-TDP pathology (40–50%), Alzheimer’s disease (AD) or other rarer pathologies [7].”
Background
Metadata
- Authors
- Perry, D. C., Brown, J. A., Possin, K. L., Datta, S., Trujillo, A., Radke, A., Karydas, A., Kornak, J., Sias, A. C., Rabinovici, G. D., Gorno-Tempini, M. L., Boxer, A. L., De May, M., Rankin, K. P., Sturm, V. E., Lee, S. E., Matthews, B. R., Kao, A. W., Vossel, K. A., Tartaglia, M. C., Miller, Z. A., Seo, S. W., Sidhu, M., Gaus, S. E., Nana, A. L., Vargas, J. N. S., Hwang, J.-H. L., Ossenkoppele, R., Brown, A. B., Huang, E. J., Coppola, G., Rosen, H. J., Geschwind, D., Trojanowski, J. Q., Grinberg, L. T., Kramer, J. H., Miller, B. L., & Seeley, W. W.
- Affiliations
- University of California, San Francisco (US)
- Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA
- University of Minnesota (US)
- University of California, Los Angeles (US)
- University of Pennsylvania (US)
- Corresponding author
- Perry, David C
- ORCID
- Perry, David C
- Brown, Jesse A
- Possin, Katherine L
- Kornak, John
- Sias, Ana C
- Rabinovici, Gil D
- Boxer, Adam L
- Rankin, Katherine P
- Sturm, Virginia E
- Lee, Suzee E
- Kao, Aimee W
- Vossel, Keith A
- Tartaglia, Maria Carmela
- Miller, Zachary A
- Seo, Sang Won
- Nana, Alissa L
- Vargas, Jose Norberto S
- Ossenkoppele, Rik
- Huang, Eric J
- Coppola, Giovanni
- Rosen, Howard J
- Geschwind, Daniel
- Trojanowski, John Q
- Grinberg, Lea T
- Kramer, Joel H
- Miller, Bruce L
- Seeley, William W
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-10-06
- Volume
- 140
- Issue
- 12
- Pages
- 3329-3345
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5841140
- OpenAlex
- W2760832975
- Cited by
- 309
- References
- 54
- Citations by year
- 2026: 15 · 2025: 39 · 2024: 35 · 2023: 38 · 2022: 56 · 2021: 39 · 2020: 29 · 2019: 34 · 2018: 23 · 2017: 1
- FWCI
- 19.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- PMC
- Funders
- National Institutes of Health (P01AG019724, P50AG023501, P30AG10124, P01AG17856, K23AG045289, U54NS092089, R01AG038791)
- BrightFocus Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- behavioral variant frontotemporal dementia, clinicopathological correlation, frontotemporal lobar degeneration, FTLD-tau, FTLD-TDP, corticobasal degeneration, progressive supranuclear palsy, Pick's disease, motor neuron disease, Alzheimer's disease, voxel-based morphometry, brain atrophy, behavioral syndromes, disease-modifying therapy, symptom profiles, neuropathology
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Autopsy, Brain, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Organ Size, Supranuclear Palsy, Progressive, Pick Disease of the Brain, Frontotemporal Lobar Degeneration, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.